CERES INC COM USD0.01..............
Seite 2 von 4 Neuester Beitrag: 25.04.21 00:05 | ||||
Eröffnet am: | 26.06.13 07:18 | von: buran | Anzahl Beiträge: | 99 |
Neuester Beitrag: | 25.04.21 00:05 | von: Julianeprhaa | Leser gesamt: | 18.305 |
Forum: | Hot-Stocks | Leser heute: | 8 | |
Bewertet mit: | ||||
Seite: < 1 | | 3 | 4 > |
22:10 03.01.14
PR Newswire
THOUSAND OAKS, Calif., Jan. 3, 2014
THOUSAND OAKS, Calif., Jan. 3, 2014 /PRNewswire/ -- Energy crop company Ceres, Inc. (Nasdaq: CERE) today announced that it will report financial results for first quarter of fiscal year 2014 on Thursday, January 9, 2014 after the close of the market. The company has scheduled a webcast and conference call for 4:30 p.m. EST (1:30 p.m. PST) to discuss its fiscal first quarter results and to provide an update on its business.
Live audio of the conference call will be webcast over the Internet and will be available to investors, members of the news media and the general public. To access the webcast of the conference call, go to investor.ceres.net. Audio of the teleconference is also available by dialing:
North America callers:
(877) 838-4153
International callers:
+1 (720) 545-0037
An audio replay of the call will be available approximately two hours after the conclusion of the live call, and remain available on the Ceres website for 30 days.
ABOUT CERES
Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.
SOURCE Ceres, Inc.
Quelle: PR Newswire
SOURCE Ceres, Inc.
Quelle: PR Newswire
buran und MfG und danke und weitermachen und hoppsassassaaaa
As part of its product development process, Ceres has also established a number of breeding and product development field evaluations across various geographies. These trials consist of hundreds of hybrids, including a subset of hybrids in advanced evaluations in Brazil and other countries in South America that have demonstrated higher yields and other performance benefits over current products.
Total plantings of the company's commercial and pre-commercial sorghum hybrids cover approximately 1,000 hectares this season. Harvests are expected to commence in late February to early March and continue through May.
In December, the company successfully completed all elements of a multi-year project funded by a competitive grant from the U.S. Department of Energy's Advanced Research Project Agency for Energy (ARPA-E). The Ceres project consisted of multi-state field evaluations of the company's high yield, low input biotech traits in three energy crops. Based on the positive results of the project, Ceres has advanced a number of these traits in its product development pipeline.
During the quarter ended November 30, 2013, Ceres was awarded a U.S. patent related to a sorghum-derived gene promoter useful for regulating the expression of genes developed through biotechnology in various crops.http://www.ariva.de/news/...st-Quarter-2014-Financial-Results-4896091
Cost of product sales was $1.3 million for the quarter ended November 30, 2013 compared to $0.7 million for the same period last year. The increase was primarily due to costs related to the company's previously reported workforce reductions and expenses for obsolete seed inventory related to the company's sweet sorghum products.
Research and development expenses were $4.4 million for the three months ended November 30, 2013 compared to $4.3 million for the same period last year. In the U.S., research and development expenses decreased by $0.6 million primarily due to reduced external research and development expenses. In Brazil, research and development expenses increased by $0.7 million primarily as a result of increased personnel and related expenses.
Selling, general and administrative expenses decreased by $0.6 million to $3.3 million for the three months ended November 30, 2013 compared to the same period last year. In the U.S., expenses decreased by $0.7 million primarily due to reduced personnel and related expenses and lower professional fees. In Brazil, expenses increased by $0.1 million primarily as a result of increased personnel and related expenses.
For the quarter ended November 30, 2013, Ceres reported a net loss of $8.2 million, or $0.33 per share, compared to a net loss of $6.9 million, or $0.28 per share, for the quarter ended November 30, 2012.
At November 30, 2013, cash and cash equivalents and marketable securities totaled $24.4 million.http://www.ariva.de/news/...st-Quarter-2014-Financial-Results-4896091
North America callers:
(877) 838-4153
International callers:
+1 (720) 545-0037
An audio replay of the call will be available two hours after the conclusion of the live call, and remain available on the Ceres website for 30 days.http://www.ariva.de/news/...st-Quarter-2014-Financial-Results-4896091
http://www.ariva.de/news/...st-Quarter-2014-Financial-Results-4896091
http://www.ariva.de/news/...st-Quarter-2014-Financial-Results-4896091
http://www.ariva.de/news/...st-Quarter-2014-Financial-Results-4896091
.http://www.ariva.de/news/...st-Quarter-2014-Financial-Results-4896091
nur hab ich oft den eindruck,
daß deine hoffung auf flugerlaubnis ein schuss in den ofen sind oder ???
träume erhalten uns am leben -)))
Kurs Stück §
16:15:09§1,49 $
300 §
16:15:09§1,49 $
1.000 §
16:15:09§1,49 $
700 §
16:15:08§1,49 $
200 §
16:15:08§1,49 $
300 §
16:15:08§1,49 $
2.500 §
16:15:08§1,49 $
3.000 §
16:11:50§1,47 $
1.500 §
16:11:50§1,48 $
100 §
16:11:50§1,47 $
532 §
16:05:00§1,47 $
182 §
15:55:21§1,47 $
200 §
15:50:15§1,46 $
100 §
15:50:15§1,46 $
3.900 §
15:50:15§1,45 $
200 §
15:32:04§1,46 $
100 §
15:31:07§1,441 $
3.500 §
15:30:00§1,44 $
682
Kosmonova buran
nächste Abfahrt realtime::: Preis pro share 1,49 $ Schleife 500 spread 0,68% unddddddddddd hier bitte nochmal fix::: Dow Jones 16.428 JOLLYPUNKTE buran und MfG und Dreimal Rosamunde
. ...mal nen fixen Gruss an halbfinne und buran hier ;-)
PR Newswire
THOUSAND OAKS, Calif., March 4, 2014
THOUSAND OAKS, Calif., March 4, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, announced today the pricing of an underwritten public offering of 20,000,000 shares of common stock at a public offering price of $1.00 per share. Ceres also granted the underwriters a 45-day option to purchase up to 3,000,000 additional shares of common stock to cover over-allotments, if any. Ceres expects to receive approximately $20 million in gross proceeds, before deducting underwriting discounts and commissions and offering expenses payable by the company. Ceres intends to use the net proceeds from this offering for general corporate purposes, including working capital.
The offering is expected to close on or about March 10, 2014, subject to the satisfaction of customary closing conditions.
Aegis Capital Corp is acting as sole book-running manager for the offering.
Trout Capital LLC acted as financial advisor to Ceres.
A registration statement on Form S-1 relating to this offering was declared effective by the U.S. Securities and Exchange Commission on March 4, 2014. This offering is being made solely by means of a written prospectus forming part of the effective registration statement relating to these securities. Copies of the prospectus relating to this offering may be obtained by contacting Aegis Capital Corp., Prospectus Department, 810 Seventh Avenue, 18th Floor, New York, NY 10019, telephone: (212) 813-1010, e-mail: prospectus@aegiscap.com. Copies of the registration statement can be accessed through the SEC's website at www.sec.gov.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
ABOUT CERES
Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.
CERES FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' public offering and its anticipated closing date, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.
SOURCE Ceres, Inc.
Quelle: PR Newswire
PR Newswire
THOUSAND OAKS, Calif., March 7, 2014
THOUSAND OAKS, Calif., March 7, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, today announced the full exercise of the over-allotment option granted to the underwriter to purchase an additional 3,000,000 shares of common stock at a public offering price of $1.00 per share, in connection with the company's recently announced underwritten public offering of 20,000,000 common shares. The full exercise of the option brings total gross proceeds from the offering to $23,000,000, before deducting underwriting discounts and commissions and other offering expenses payable by the company.
The offering is expected to close on or about March 10, 2014, subject to the satisfaction of customary closing conditions.
Aegis Capital Corp is acting as sole book-running manager for the offering.
Trout Capital LLC is acting as financial advisor to Ceres.
A registration statement on Form S-1 relating to this offering was declared effective by the U.S. Securities and Exchange Commission on March 4, 2014. This offering is being made solely by means of a written prospectus forming part of the effective registration statement relating to these securities. Copies of the prospectus relating to this offering may be obtained by contacting Aegis Capital Corp., Prospectus Department, 810 Seventh Avenue, 18th Floor, New York, NY 10019, telephone: (212) 813-1010, e-mail: prospectus@aegiscap.com. Copies of the registration statement can be accessed through the SEC's website at www.sec.gov.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
ABOUT CERES
Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.
CERES FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' public offering and its anticipated closing date, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.
SOURCE Ceres, Inc.
Quelle: PR Newswire
In Euro: 0,7709 € | Nasdaq, 07.03.14:::::: Kosmonova buran ..::hopshopshopshops
PR Newswire
THOUSAND OAKS, Calif., March 10, 2014
THOUSAND OAKS, Calif., March 10, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, announced today the closing of its previously announced underwritten public offering of 20,000,000 shares of common stock at a public offering price of $1.00 per share. In connection with this offering, the underwriter exercised in full its option to purchase an additional 3,000,000 shares of common stock from the company. Total gross proceeds from the offering were $23,000,000, before deducting underwriting discounts and commissions and other offering expenses payable by the company.
Aegis Capital Corp acted as sole book-running manager for the offering.
Trout Capital LLC acted as financial advisor to Ceres.
A registration statement on Form S-1 relating to this offering was declared effective by the U.S. Securities and Exchange Commission on March 4, 2014. This offering is being made solely by means of a written prospectus forming part of the effective registration statement relating to these securities. Copies of the prospectus relating to this offering may be obtained by contacting Aegis Capital Corp., Prospectus Department, 810 Seventh Avenue, 18th Floor, New York, NY 10019, telephone: (212) 813-1010, e-mail: prospectus@aegiscap.com. Copies of the registration statement can be accessed through the SEC's website at www.sec.gov.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
ABOUT CERES
Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.
CERES FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. All statements, other than statements of historical facts, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.
SOURCE Ceres, Inc.
Quelle: PR Newswire
22:05 03.04.14
PR Newswire
THOUSAND OAKS, Calif., April 3, 2014
THOUSAND OAKS, Calif., April 3, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, today announced that it will report financial results for the second quarter of fiscal year 2014 on Thursday, April 10, 2014 after the close of the market. The company has scheduled a webcast and conference call for 4:30 p.m. EDT (1:30 p.m. PDT) to discuss its fiscal second quarter results and to provide an update on its business.
Live audio of the conference call will be webcast over the Internet and will be available to investors, members of the news media and the general public. To access the webcast of the conference call, go to investor.ceres.net. Audio of the teleconference is also available by dialing:
North America callers:
(877) 838-4153
International callers:
+1 (720) 545-0037
An audio replay of the call will be available approximately two hours after the conclusion of the live call, and remain available on the Ceres website for 30 days.
ABOUT CERES
Ceres, Inc. (www.ceres.net) is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.
SOURCE Ceres, Inc.
Quelle: PR Newswire